FDA fast-track approval of belzutifan is a milestone in rare cancer therapy.
作者信息
Arenillas Carlota, Toledo Rodrigo A
机构信息
Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
出版信息
Nat Rev Endocrinol. 2025 Sep 11. doi: 10.1038/s41574-025-01183-z.
PMID:40935878
Abstract
摘要
Zotero 插件